According to CRISPR Therapeutics's latest financial reports the company's current earnings are ยฃ0.20 Billion. In 2023 the company made an earning of -ยฃ0.12 Billion, an increase over its 2022 earnings that were of -ยฃ0.51 Billion. The earnings displayed on this page is the company's Pretax Income.